Thank heavens we don't have to put up with any further profit reports from this under-performer. Now just give us the money as we might be able to pick a better investment next time.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025